Browse the corpus

The primary objective of antenatal fetal surveillance is to mitigate the risk of stillbirth. Fetal heart rate patterns, activity levels, and muscle tone are indicators that can be affected by hypoxemia and acidemia. When a fetus experiences hypoxemia, blood flow redistribution can lead to reduced renal perfusion and oligohydramnios. Antenatal fetal surveillance modalities are used to detect potential uteroplacental compromise, allowing for intervention before metabolic acidosis can progress to fetal death. Various surveillance methods include maternal perception of fetal movement, contraction stress tests, nonstress tests, biophysical profiles, and umbilical artery Doppler velocimetry. Normal results from these tests are generally reassuring due to their low false-negative rates, but results should be interpreted within the broader clinical context, with further testing or intervention guided by the overall maternal and fetal condition. The management of equivocal or abnormal BPP scores varies based on gestational age. Ultimately, abnormal test results necessitate careful evaluation to avoid unnecessary interventions. This activity for healthcare professionals is designed to enhance the learner's competence in performing antenatal fetal surveillance, appropriately interpreting findings clinically, and implementing effective interprofessional management approaches to improve patient outcomes. Objectives: Identify the indications for antenatal fetal surveillance. Differentiate between available antenatal fetal surveillance techniques. Interpret the findings for each antenatal fetal surveillance modality. Implement interprofessional team strategies to improve care coordination and outcomes in patients undergoing antenatal fetal surveillance. Access free multiple choice questions on this topic.

The primary objective of antenatal fetal surveillance is to mitigate the risk of stillbirth. For nearly 4 decades, techniques assessing fetal heart rate (FHR) patterns, alongside real-time ultrasonography and umbilical artery Doppler velocimetry, have been used to monitor fetal well-being. These methods are crucial for evaluating the risk of fetal death in pregnancies with preexisting maternal conditions, such as diabetes mellitus, or those complicated by issues such as fetal growth restriction. FHR patterns, activity levels, and muscle tone are indicators that can be affected by hypoxemia and acidemia. When a fetus experiences hypoxemia, blood flow redistribution can lead to reduced renal perfusion and oligohydramnios. Techniques such as cardiotocography, real-time ultrasonography, and monitoring maternal perception of fetal movements are used to detect potential uteroplacental compromise. Identifying fetal compromise allows for intervention before metabolic acidosis can progress to fetal death. However, sudden and severe changes in fetal status, such as placental abruption or umbilical cord accidents, are typically unpredictable and less preventable through these tests.[1][2]

The primary objective of antenatal fetal surveillance is to mitigate the risk of stillbirth. For nearly 4 decades, techniques assessing fetal heart rate (FHR) patterns, alongside real-time ultrasonography and umbilical artery Doppler velocimetry, have been used to monitor fetal well-being. These methods are crucial for evaluating the risk of fetal death in pregnancies with preexisting maternal conditions, such as diabetes mellitus, or those complicated by issues such as fetal growth restriction. FHR patterns, activity levels, and muscle tone are indicators that can be affected by hypoxemia and acidemia. When a fetus experiences hypoxemia, blood flow redistribution can lead to reduced renal perfusion and oligohydramnios. Techniques such as cardiotocography, real-time ultrasonography, and monitoring maternal perception of fetal movements are used to detect potential uteroplacental compromise. Identifying fetal compromise allows for intervention before metabolic acidosis can progress to fetal death. However, sudden and severe changes in fetal status, such as placental abruption or umbilical cord accidents, are typically unpredictable and less preventable through these tests.[1][2] The American College of Obstetricians and Gynecologists (ACOG) has provided general recommendations on when to initiate antenatal fetal surveillance based on the risk of stillbirth; however, strict guidelines have not been established due to the limited amount of evidence-based studies. Consequently, the ACOG encourages antenatal fetal surveillance to be individualized, including initiation, modalities utilized, and frequency, especially in high-risk cases where surveillance might begin at an age where delivery benefits perinatal outcomes. Antenatal fetal surveillance is indicated for conditions with a stillbirth incidence higher than 0.8 per 1000 and a relative risk or odds ratio for stillbirth >2.0 compared to unaffected pregnancies. In the absence of gestational age-adjusted data, ACOG suggests initiating surveillance at 32, 36, or 39 weeks of gestation. Shared decision-making between the patient and clinician is essential, particularly for pregnancies at a high risk of stillbirth or for those with multiple complicating factors. This approach is crucial when dealing with fetal anomalies or initiating surveillance near the threshold of viability, where patient preferences significantly influence care decisions.[1][2]

The American College of Obstetricians and Gynecologists (ACOG) has provided general recommendations on when to initiate antenatal fetal surveillance based on the risk of stillbirth; however, strict guidelines have not been established due to the limited amount of evidence-based studies. Consequently, the ACOG encourages antenatal fetal surveillance to be individualized, including initiation, modalities utilized, and frequency, especially in high-risk cases where surveillance might begin at an age where delivery benefits perinatal outcomes. Antenatal fetal surveillance is indicated for conditions with a stillbirth incidence higher than 0.8 per 1000 and a relative risk or odds ratio for stillbirth >2.0 compared to unaffected pregnancies. In the absence of gestational age-adjusted data, ACOG suggests initiating surveillance at 32, 36, or 39 weeks of gestation. Shared decision-making between the patient and clinician is essential, particularly for pregnancies at a high risk of stillbirth or for those with multiple complicating factors. This approach is crucial when dealing with fetal anomalies or initiating surveillance near the threshold of viability, where patient preferences significantly influence care decisions.[1][2] Various surveillance methods include maternal perception of fetal movement, contraction stress tests (CSTs), nonstress tests (NSTs), biophysical profiles (BPPs), modified BPPs, and umbilical artery Doppler velocimetry. Generally, normal results from these tests are reassuring due to their low false-negative rates. However, antenatal fetal surveillance using any modality may not accurately reflect a significantly affected fetus during acute distress and is less effective at predicting stillbirths resulting from acute maternal-fetal status changes. In addition, some maternal conditions may cause temporary abnormal results during fetal testing that improve as the maternal condition improves. Therefore, abnormal test results should be interpreted within the broader clinical context, with further testing or intervention guided by the overall maternal and fetal condition.[1][2]

Various surveillance methods include maternal perception of fetal movement, contraction stress tests (CSTs), nonstress tests (NSTs), biophysical profiles (BPPs), modified BPPs, and umbilical artery Doppler velocimetry. Generally, normal results from these tests are reassuring due to their low false-negative rates. However, antenatal fetal surveillance using any modality may not accurately reflect a significantly affected fetus during acute distress and is less effective at predicting stillbirths resulting from acute maternal-fetal status changes. In addition, some maternal conditions may cause temporary abnormal results during fetal testing that improve as the maternal condition improves. Therefore, abnormal test results should be interpreted within the broader clinical context, with further testing or intervention guided by the overall maternal and fetal condition.[1][2] In cases of decreased maternal perception of fetal movement, further assessment with NSTs, CSTs, BPPs, or modified BPPs is recommended. Abnormal findings typically lead to additional testing or consideration of delivery. The management of equivocal or abnormal BPP scores varies based on gestational age. For scores of 4 or lower, delivery is often indicated unless the pregnancy is less than 32 weeks, where extended monitoring may be appropriate. Ultimately, abnormal test results necessitate careful evaluation to avoid unnecessary interventions. Continuous intrapartum monitoring is advisable if delivery is attempted. Although fetal kick counting is a simple method to assess fetal well-being, its effectiveness in preventing stillbirth is not well-established and might lead to increased medical interventions.[1][2]

Antenatal fetal surveillance carries the potential for several harms, including false-positive results that can lead to unnecessary additional evaluations or interventions, such as iatrogenic preterm birth. False-negative results, which fail to signal the need for further assessment, also pose a risk.[2] Some experts have also suggested that a risk of antenatal fetal surveillance may be the delivery of infants with severe conditions, such as cerebral palsy, due to nonreassuring test results, potentially resulting in the survival of fetuses with a permanent neurological impairment that might otherwise have resulted in fetal demise.[14] In addition, the effects of antenatal testing on maternal mental health are not well understood; testing may induce complications such as anxiety but also provide reassurance if results are normal.[15] Costs associated with antenatal testing include financial expenditures, time spent by patients and healthcare practitioners, and potential maternal and infant morbidity from unnecessary interventions due to false-positive results.[16][3] Generally, the use of ultrasound in obstetrics is considered safe. However, the ACOG guided the limited use of interventions in pregnancy.[17][18][19] The ACOG stated that although ultrasound is accepted as a safe study, the potential effects of prolonged or repeated exposure to ultrasound waves on a fetus can not be definitively determined. Therefore, the As Low As Reasonably Achievable (ALARA) principle is encouraged, in which interventions, such as ultrasound, are only implemented with specific indications.[20] Clinicians should be mindful of the thermal energy released by the probe, which shows in the margins of the ultrasound display as a thermal index, a ratio of the acoustic power emitted by the transducer to the power necessary to raise the temperature of the tissue 1 °C anywhere along the beam. Ideally, recommendations are for settings that have the lowest thermal index.

Effective antenatal fetal surveillance requires a collaborative approach involving various health professionals, each contributing unique skills and responsibilities to enhance patient-centered care, improve outcomes, ensure patient safety, and optimize team performance. Physicians play a pivotal role in diagnosing and managing conditions requiring fetal surveillance, interpreting complex data, and making critical decisions about the care plan. Advanced practitioners, such as nurses and physician assistants, support these efforts by conducting detailed patient assessments, counseling, and managing routine follow-up visits. Nurses are essential in educating and supporting patients, performing initial assessments, and monitoring fetal well-being through NSTs and other methods. Pharmacists contribute by ensuring the safe and effective use of medications required during antenatal care, such as those used to manage conditions such as hypertension or diabetes. Interprofessional communication is crucial in this context, as timely and accurate information exchange among team members ensures coordinated and efficient care. For instance, nurses must promptly communicate any findings from fetal monitoring to physicians or advanced practitioners, who may then need to update the team on changes in the patient's condition or response to treatment. Care coordination involves scheduling and managing appointments, ensuring all necessary tests are performed, and maintaining comprehensive records accessible to all team members. By leveraging the strengths and expertise of each team member, the healthcare team can provide holistic and responsive care that prioritizes the well-being of both the mother and the fetus. Ultimately, this integrated approach to antenatal fetal surveillance ensures that patients receive the highest quality of care, minimizes risks, prevents errors, and enhances patient safety by ensuring no aspect of care is overlooked, leading to better health outcomes and patient satisfaction.